Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

PRIMO 2024 | Exploring immunotherapy trends in the uterine cancer treatment landscape

Ritu Salani • 29 Feb 2024
PRIMO 2024
Gynecological Cancer

Ritu Salani, MD, MBA, UCLA Health in Los Angeles, CA, discusses the evolving treatment landscape in uterine cancer, particularly the increasing interest in exploring immunotherapy options. This includes investigating combinations of immunotherapy agents or sequential therapies. This interview took place at the 2024 PRIMO meeting in Honolulu, Hawaii.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Ritu Salani

1:09
Broadening horizons in immuno-oncology: insights from PRIMO 2024
Ritu Salani • 29 Feb 2024
1:33
The future of immunotherapy evolving in the management of uterine cancer
Ritu Salani • 29 Feb 2024
0:45
Advancing uterine cancer management
Ritu Salani • 29 Feb 2024
1:08
Implications of phase III trials in endometrial cancer: dMMR patients and immunotherapy
Ritu Salani • 29 Feb 2024

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:11
Clonal hematopoiesis mutations in ovarian carcinomas
Rebecca Porter • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals